Department of Medicine–

Ash A. Alizadeh, MD/PhD

Back to Profile

Publication Details

  • Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors.

    Pollyea DA, Raval A, Kusler B, Gotlib JR, Alizadeh AA, Mitchell BS. Hematol Oncol. 2011; 29 (3): 157-60

    PubMedID: 21922510

Stanford Medicine Resources:

Footer Links: